This report describes a method of estimating the duration of fungicidal activity of amphotericin B in the vagina after its insertion in a cream base.
Various localized vaginal infections are treated by the insertion of a pessary or cream into the vagina. This method of treatment is not entirely satisfactory since failure to respond may be due to the method of application rather than to the limitations of the preparation or the resistance of the infection to the active principle.
The effectiveness of this procedure depends on the distribution of the active principle over the whole surface of the vaginal mucosa. A variety of factors may combine to prevent or delay this dispersal. When inserting a pessary the patient may fail to introduce it high enough into the vagina to ensure uniform spread throughout its surface. The composition of a pessary together with local anatomical, physiological, or pathological conditions may prevent its rapid and complete disintegration, thereby delaying the liberation of the active principle. Although much work has been done on the composition of pessaries to ensure their rapid disintegration in the vagina, the practical difficulties of application remain and make the efficacy of this particular form of treatment extremely difficult to assess in any individual patient.
In some respects the use of a cream inserted with an applicator is preferable to a pessary. The cream spreads more uniformly over the vaginal mucosa but the amount of leakage varies considerably between patients. A pregnant ambulant multiparous woman near term may lose a very substantial proportion of the total dose in this way.
Whichever vehicle is used, the convenience of the patient demands that the active principle should be present in effective concentrations at all vaginal sites for at least 24 hours, or a multiple thereof, so 235 that the patient can insert the cream or pessary on going to bed. This also avoids much of the early leakage which occurs in the ambulant patient. But whether or not effective vaginal concentrations are maintained for 24 hours in any individual patient is unknown to the clinician. Failure to maintain such concentrations may account for a proportion of treatment failures. This single factor may explain the poorer response to treatment reported in pregnant as opposed to non-pregnant patients treated for vaginal candidiasis (Jennison, 1958; Ewing, 1967) .
Until a satisfactory method is devised for estimating the concentration of a preparation in the vagina at a given time after its introduction, the effect of this factor on the results of treatment will remain unknown. No satisfactory method of estimating such concentrations has so far been described, and the results of assays can be extremely variable, especially after the use of a pessary. The sample for assay may be derived from a mass of pessary debris lying partly disintegrated in the posterior fornix. Alternatively the sample may be obtained from an area to which minimum dispersal has taken place. In either case the results obtained would give an inaccurate picture of the concentrations present in all areas of the vagina.
In this trial a cream* was preferred to a pessary since its more uniform distribution over the vaginal surface was thought likely to give more dependable assays.
The method of sampling vaginal concentrations here describedt avoids the danger of obtaining an unrepresentative sample from a single vaginal site and is presented as an improved method for estimating the survival time of any preparation administered in this way.
All patients were treated at clinic sessions, either in the morning or early evening, and thus were ambulant immediately afterwards for the whole or part of the day. If this had any effect on the vaginal concentrations subsequently recorded it could only be to reduce them as compared with those which would have been obtained if the patient had remained at rest in bed for approximately 8 hours after the insertion of the cream. Evidence is presented below to show that the extent of partition is reasonably constant, and the relation between the amount of amphotericin B inserted into the vagina and that recovered from the tampon is described.
Method
After the sampling tampon had been removed from the vagina its absorbed amphotericin B was extracted in a solvent and assayed against a standard preparation by a microbiological diffusion-zone assay method of the parallel-line type commonly used for antibiotics.
Subjects
All the patients were ambulant adult females who volunteered to co-operate, but many failed to attend at the appointed times and had to be excluded from the trial, so that the analysis of results concerns only patients who completed the trial satisfactorily.
The first fourteen patients had a tampon inserted into the vagina immediately after the introduction of the amphotericin B cream; 24 hours later the tampon was removed and the amount of amphotericin B absorbed by the tampon was assayed. The results in these fourteen patients were used as a control. Two women in this group were pregnant, both primiparae. The age range was 17 to 28 years (average 20 7).
In the next ten cases the tampon was inserted 24 hours after the introduction of the cream and was left in situ for 24 hours to absorb any remaining amphotericin B. It was then removed for assay. Six of the ten patients in this group were pregnant, all primiparae. The age range was 16 to 20 years (average 18-3).
In a further group of ten patients the tampon was inserted 48 hours after the introduction of the cream, and was removed for assay after remaining in situ for 24 hours. Fig. 1 (opposite). The region marked "A" is that where the response depended only on amphotericin B concentration; the region marked "B" illustrated the additional pH-solubility effect. Tampon extracts were diluted so that their responses fell into region "A", thus allowing a true "parallel-line" method of comparison. Very occasionally an extract gave responses which fell into region "B" thus necessitating a "parallel-line" comparison with this valid but less sensitive region of the response function. Preparation of the Assay Plate.-Two 100 ml. amounts of medium were used for each plate. The medium, after melting, was held at 50°C. in a water-bath.
The assay plate was set upon a specially levelled surface. 100 ml. of agar was poured into the plate to form a basal layer and allowed to solidify. The remaining bottle was inoculated with 2 -5 ml. of Saccharomyces cereviseae suspension. After being mixed by gentle agitation, the contents of the bottle were poured over the basal layer to form the inoculum layer. The plate was placed at 4°C. for 30 minutes to harden the medium before cutting reservoirs and to arrest the growth of the indicator strain.
Preparation of Samples for Assay.-100 ml. formdimethylamide was added to each tampon. The amphotericin B was extracted by shaking for 15 minutes on a mechanical shaker. Dilutions were made in buffer solution to give an estimated 2 and 1 ,tg./ml. The amphotericin B control was diluted to concentrations of 8, 4, 2, and 1 ,ug./ml. in order to span the regions "A" and "B" of Fig. 1 The final estimate of the amount of amphotericin B absorbed by a tampon (in mg.) was obtained by multiplication of (R) by the following factors:
(a) the concentration of the higher standard solution of the appropriate region "A" or "B" (see Fig. 1 ). (b) any dilution factor. (c) the volume of fluid (100 ml.) in which the tampon was extracted.
In order to attempt a more precise interpretation of the data, an Analysis of Regression was performed on the results of the "zero time" group. This showed that the amounts of active principle recovered (y) could be represented, within statistical limits of variation, by a simple linear function of the amount inserted (x).
Fig 2 shows a plot of this function, which can be represented as y =mx, where m represents the regression constant. Numerically, the "least squares" estimate of m was 0-429. Thus, over the range from 0 to 53-5 mg. active principle inserted, the amount recovered by the sampling method was 42 *9 per cent. when sampling was begun immediately after insertion. Results It was found that all the sampling tampons were evenly stained, thus supporting the view that the cream had been distributed with reasonable uniformity throughout the vagina. Table I shows the results obtained from fourteen patients in whom sampling tampons were inserted immediately after application of amphotericin B (zero time group) and from ten patients in whom sampling was begun 24 hours after application (24-hr sample group). The vital statistics of these patients are not given in detail since the whole experimental group was fairly homogeneous. Table I reveals that the amount of active amphotericin B recovered from the "zero time" group was assayed as roughly 45 per cent. of that inserted, whereas only about 2 per cent. was recovered from the "24-hr sample" group. We next applied these findings to the data of the "24-hr sample" group, arguing that, if the amount of active amphotericin B recovered from a tampon was y mg., then it was likely that the amount actually in the vagina during the sampling period (x mg.) was: The data for the groups of patients in whom sampling was begun 48 hours or 72 hours after insertion are not presented since, although each of these patients received about 50 mg. active amphotericin B, in no case was a measurable amount detected by the assay of tampon extract. The lower limit of sensitivity of the assay method corresponds The efficacy of amphotericin B as a fungicidal agent is well documented (Jennison, 1958; Stough and Blank, 1958; Hildick-Smith, Blank, and Sarkany, 1964) , and it was not the purpose of this trial to assess the clinical effectiveness of this agent when incorporated in a cream base. The number of patients was too small to warrant firm conclusions on the clinical responses, nor is amphotericin B marketed as a vaginal cream. The results suggest, however, that such a cream might provide a very useful addition to the preparations at present available for the local treatment of vaginal candidiasis. Table II shows the amount of amphotericin B inserted in the cases of ten ambulant patients (col. 2) , and the estimated amounts still present in the vagina of each of these patients 24 hours later (col. 4). These estimated amounts are recorded with much greater confidence than would have been possible if the samples for assay had been taken by the usual methods. In addition it is likely that the amounts recorded underestimate the actual amounts present in these cases at 24 hours, since the amounts present at that time must have been at least as great as those which could be calculated from that absorbed by the tampon during the subsequent 24 hours.
The average amount of amphotericin B contained in an applicator full of the cream used in this trial was approximately 48 mg. After 24 hours the estimated amount still present in the vagina averaged 2-29 mg. Since the minimal inhibitory concentration of amphotericin B to Candida albicans is only 0 0005 mg./ml., it is very likely that in this small series of ambulant patients clinically effective amounts of amphotericin B persisted in the vagina for 24 hours in all ten cases. The validity of this observation can be determined only by clinical trials, since there is no way of proving that the presence of a given amount of active principle will result in a minimal inhibitory concentration at all vaginal sites for sufficient time to ensure successful treatment. Summary A method is described for estimating the persistence of any preparation inserted into the vagina. A statistical analysis of results is recorded.
A cream containing 48 mg. amphotericin B was shown to persist in the vagina for at least 24 hours, after which an average of 2 29 mg. of the active principle was recovered. It is considered that this dosage is likely to be clinically effective when repeated at intervals of 24 hours.
